Paper28486997
The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis.
Alqaisi AQI and 4 others. Parasitology, 2018. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis. Papers, record 28486997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28486997
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifungal Agents | Major topic |
| Depsipeptides | Major topic |
| Sphingolipids | Major topic |
| Toxoplasma | Major topic |
| Animals | |
| Fibroblasts | |
| Foreskin | |
| Hexosyltransferases | |
| Humans | |
| Life Cycle Stages | |
| Male | |
| Toxoplasmosis | |
| Toxoplasmosis, Animal |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 28595661 | The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis - Corrigendum. | https://conductscience.org/library/papers/28595661 |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23449981 | Ceramide phosphoethanolamine biosynthesis in Drosophila is mediated by a unique ethanolamine phosphotransferase in the Golgi lumen. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23449981 | PubMed |
| 2 | 15973004 | Sphingolipids in infectious diseases. | Jpn J Infect Dis | 2005 | https://conductscience.org/library/papers/15973004 | PubMed |
| 3 | 19047657 | Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19047657 | PubMed |
| 4 | 8593016 | The AUR1 gene in Saccharomyces cerevisiae encodes dominant resistance to the antifungal agent aureobasidin A (LY295337). | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/8593016 | PubMed |
| 5 | 16861742 | The protozoan inositol phosphorylceramide synthase: a novel drug target that defines a new class of sphingolipid synthase. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16861742 | PubMed |
| 6 | 12912895 | Formation and remodeling of inositolphosphoceramide during differentiation of Trypanosoma cruzi from trypomastigote to amastigote. | Eukaryot Cell | 2003 | https://conductscience.org/library/papers/12912895 | PubMed |
| 7 | 14685263 | Identification of a family of animal sphingomyelin synthases. | EMBO J | 2004 | https://conductscience.org/library/papers/14685263 | PubMed |
| 8 | 15569002 | Characterization of the inositol phosphorylceramide synthase activity from Trypanosoma cruzi. | Biochem J | 2005 | https://conductscience.org/library/papers/15569002 | PubMed |
| 9 | 23246819 | Sphingolipid synthesis and scavenging in the intracellular apicomplexan parasite, Toxoplasma gondii. | Mol Biochem Parasitol | 2013 | https://conductscience.org/library/papers/23246819 | PubMed |
| 10 | 17404298 | Toxoplasma gondii dysregulates IFN-gamma-inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling. | J Immunol | 2007 | https://conductscience.org/library/papers/17404298 | PubMed |
| 11 | 24162026 | Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies. | Nat Rev Microbiol | 2013 | https://conductscience.org/library/papers/24162026 | PubMed |
| 12 | 9092515 | Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9092515 | PubMed |
| 13 | 11166384 | Biosynthesis of glycosphingolipids de-novo by the human malaria parasite Plasmodium falciparum. | Mol Biochem Parasitol | 2001 | https://conductscience.org/library/papers/11166384 | PubMed |
| 14 | 23615442 | Toxoplasma gondii salvages sphingolipids from the host Golgi through the rerouting of selected Rab vesicles to the parasitophorous vacuole. | Mol Biol Cell | 2013 | https://conductscience.org/library/papers/23615442 | PubMed |
| 15 | 26101567 | Generation of Broad-Spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin A. | ACS Med Chem Lett | 2015 | https://conductscience.org/library/papers/26101567 | PubMed |
| 16 | 8206135 | Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. | Exp Parasitol | 1994 | https://conductscience.org/library/papers/8206135 | PubMed |
| 17 | 12062486 | Evidence for de novo sphingolipid biosynthesis in Toxoplasma gondii. | Int J Parasitol | 2002 | https://conductscience.org/library/papers/12062486 | PubMed |
| 18 | 1429697 | Sphingolipids are essential for the growth of Chinese hamster ovary cells. Restoration of the growth of a mutant defective in sphingoid base biosynthesis by exogenous sphingolipids. | J Biol Chem | 1992 | https://conductscience.org/library/papers/1429697 | PubMed |
| 19 | 27470411 | Human toxoplasmosis-Searching for novel chemotherapeutics. | Biomed Pharmacother | 2016 | https://conductscience.org/library/papers/27470411 | PubMed |
| 20 | 9177342 | Functional rafts in cell membranes. | Nature | 1997 | https://conductscience.org/library/papers/9177342 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41708645 | Molecular insights into fungal inositol phosphorylceramide synthesis and its inhibition by antifungal aureobasidin A. | Nat Commun | 2026 | https://conductscience.org/library/papers/41708645 | PubMed |
| 37795915 | Toxoplasma ceramide synthases: Gene duplication, functional divergence, and roles in parasite fitness. | FASEB J | 2023 | https://conductscience.org/library/papers/37795915 | PubMed |
| 37729272 | Disruption of the inositol phosphorylceramide synthase gene affects Trypanosoma cruzi differentiation and infection capacity. | PLoS Negl Trop Dis | 2023 | https://conductscience.org/library/papers/37729272 | PubMed |
| 35977499 | Ceramide biosynthesis is critical for establishment of the intracellular niche of Toxoplasma gondii. | Cell Rep | 2022 | https://conductscience.org/library/papers/35977499 | PubMed |
| 32825250 | Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway. | J Fungi (Basel) | 2020 | https://conductscience.org/library/papers/32825250 | PubMed |
| 31120963 | Expression levels of inositol phosphorylceramide synthase modulate plant responses to biotic and abiotic stress in Arabidopsis thaliana. | PLoS One | 2019 | https://conductscience.org/library/papers/31120963 | PubMed |
| 30158461 | Functional Analyses of a Putative, Membrane-Bound, Peroxisomal Protein Import Mechanism from the Apicomplexan Protozoan Toxoplasma gondii. | Genes (Basel) | 2018 | https://conductscience.org/library/papers/30158461 | PubMed |
| 30088074 | Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review. | Parasitol Res | 2018 | https://conductscience.org/library/papers/30088074 | PubMed |
| 29143719 | Microbial protein targets: towards understanding and intervention. | Parasitology | 2018 | https://conductscience.org/library/papers/29143719 | PubMed |
| 28637533 | Everybody needs sphingolipids, right! Mining for new drug targets in protozoan sphingolipid biosynthesis. | Parasitology | 2018 | https://conductscience.org/library/papers/28637533 | PubMed |
| 28595661 | The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis - Corrigendum. | Parasitology | 2018 | https://conductscience.org/library/papers/28595661 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SGMS2 | 166929 | PubTator's text mining | https://conductscience.org/library/genes/166929 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28486997
GET https://conductscience.org/api/papers/v1/28486997/references?page=2